CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Kojic

曲酸 杂质对照品Kojic Impurities

31 个杂质条目31 impurity entries

本页汇总 曲酸 的 31 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 31 impurity reference standards of Kojic. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 曲酸(Kojic)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesComparative Stability of Two Anti-hyperpigmentation Agents: Kojic Acid as a Natural Metabolite and Its Di-Palmitate Ester, Under Oxidative Stress; Application to Pharmaceutical Formulation Design
    Advanced pharmaceutical bulletin · 2022 · Tazesh S et al.  ·  PMID 35620332  ·  DOI
  2. 杂质研究Impurity studiesEvaluation of the repeated-dose liver, bone marrow and peripheral blood micronucleus and comet assays using kojic acid
    Mutation research. Genetic toxicology and environmental mutagenesis · 2015 · Ogiwara Y et al.  ·  PMID 25892630  ·  DOI
  3. 杂质研究Impurity studiesNon-genotoxic mode of action and possible threshold for hepatocarcinogenicity of Kojic acid in F344 rats
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2011 · Chusiri Y et al.  ·  PMID 21112367  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisClick linker: efficient and high yielding synthesis of a new family of kojic acid congeners as cytotoxic agents
    Natural product research · 2023 · Ravirala S et al.  ·  PMID 34720015  ·  DOI
  • 合成方法SynthesisOptimisation and Characterisation of Lipase-Catalysed Synthesis of a Kojic Monooleate Ester in a Solvent-Free System by Response Surface Methodology
    PloS one · 2015 · Jumbri K et al.  ·  PMID 26657030  ·  DOI

曲酸 —— 原料药与杂质对照品Kojic — drug substance & impurities

共 32 个条目(含原料药本体)32 items incl. the drug substance
Kojic structure
原料药 APIAPI
曲酸Kojic
Kojic
CAS No.79725-98-7
Chemical FormulaC38H66O6
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 1 Sodium Salt structure
1
曲酸杂质1 钠盐Kojic Impurity 1 Sodium Salt
Kojic Impurity 1 Sodium Salt
CAS No.123531-57-7
Chemical FormulaC6H5O4-·Na+
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 1 structure
1
曲酸杂质1Kojic Impurity 1
Kojic Impurity 1
CAS No.501-30-4
Chemical FormulaC6H6O4
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 2 structure
2
曲酸杂质2Kojic Impurity 2
Kojic Impurity 2
CAS No.644-46-2
Chemical FormulaC6H6O3
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 3 structure
3
曲酸杂质3Kojic Impurity 3
Kojic Impurity 3
CAS No.15771-06-9
Chemical FormulaC13H12O4
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 4 structure
4
曲酸杂质4Kojic Impurity 4
Kojic Impurity 4
CAS No.7559-81-1
Chemical FormulaC6H5ClO3
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 5 structure
5
曲酸杂质5Kojic Impurity 5
Kojic Impurity 5
CAS No.1246060-75-2
Chemical FormulaC13H10Cl2N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 6 structure
6
曲酸杂质6Kojic Impurity 6
Kojic Impurity 6
CAS No.6269-25-6
Chemical FormulaC7H8O4
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 7 structure
7
曲酸杂质7Kojic Impurity 7
Kojic Impurity 7
CAS No.2029-49-4
Chemical FormulaC7H8O5
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 8 structure
8
曲酸杂质8Kojic Impurity 8
Kojic Impurity 8
CAS No.497-59-6
Chemical FormulaC7H4O7
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 9 structure
9
曲酸杂质9Kojic Impurity 9
Kojic Impurity 9
CAS No.499-78-5
Chemical FormulaC6H4O5
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 10 structure
10
曲酸杂质10Kojic Impurity 10
Kojic Impurity 10
CAS No.496-63-9
Chemical FormulaC5H4O3
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 11 structure
11
曲酸杂质11Kojic Impurity 11
Kojic Impurity 11
CAS No.61160-18-7
Chemical FormulaC13H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 13 structure
13
曲酸杂质13Kojic Impurity 13
Kojic Impurity 13
CAS No.30652-12-1
Chemical FormulaC8H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 14 structure
14
曲酸杂质14Kojic Impurity 14
Kojic Impurity 14
CAS No.4940-11-8
Chemical FormulaC7H8O3
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 15 structure
15
曲酸杂质15Kojic Impurity 15
Kojic Impurity 15
CAS No.220757-73-3
Chemical FormulaC8H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 16 structure
16
曲酸杂质16Kojic Impurity 16
Kojic Impurity 16
CAS No.2308-51-2
Chemical FormulaC6H6O5
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 17 structure
17
曲酸杂质17Kojic Impurity 17
Kojic Impurity 17
CAS No.68642-64-8
Chemical FormulaC6H7NO3
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 18 structure
18
曲酸杂质18Kojic Impurity 18
Kojic Impurity 18
CAS No.532-34-3
Chemical FormulaC12H18O4
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 19 structure
19
曲酸杂质19Kojic Impurity 19
Kojic Impurity 19
CAS No.675-10-5
Chemical FormulaC6H6O3
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 20 structure
20
曲酸杂质20Kojic Impurity 20
Kojic Impurity 20
CAS No.1121-23-9
Chemical FormulaC5H5NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 21 structure
21
曲酸杂质21Kojic Impurity 21
Kojic Impurity 21
CAS No.50700-61-3
Chemical FormulaC6H7NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 22 structure
22
曲酸杂质22Kojic Impurity 22
Kojic Impurity 22
CAS No.99110-81-3
Chemical FormulaC7H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 23 structure
23
曲酸杂质23Kojic Impurity 23
Kojic Impurity 23
CAS No.104764-53-6
Chemical FormulaC8H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 24 structure
24
曲酸杂质24Kojic Impurity 24
Kojic Impurity 24
CAS No.30652-14-3
Chemical FormulaC9H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 25 structure
25
曲酸杂质25Kojic Impurity 25
Kojic Impurity 25
CAS No.125757-81-5
Chemical FormulaC7H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 26 structure
26
曲酸杂质26Kojic Impurity 26
Kojic Impurity 26
CAS No.115864-73-8
Chemical FormulaC8H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 27 structure
27
曲酸杂质27Kojic Impurity 27
Kojic Impurity 27
CAS No.115900-75-9
Chemical FormulaC9H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 28 structure
28
曲酸杂质28Kojic Impurity 28
Kojic Impurity 28
CAS No.148351-86-4
Chemical FormulaC10H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 29 structure
29
曲酸杂质29Kojic Impurity 29
Kojic Impurity 29
CAS No.60403-96-5
Chemical FormulaC7H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 30 structure
30
曲酸杂质30Kojic Impurity 30
Kojic Impurity 30
CAS No.95264-52-1
Chemical FormulaC6H7NO2
Purity>95%询价On request
10mg25mg50mg100mg
Kojic Impurity 31 structure
31
曲酸杂质31Kojic Impurity 31
Kojic Impurity 31
CAS No.327175-05-3
Chemical FormulaC12H16O4
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

曲酸 —— 研究文献与合成路线Kojic — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 曲酸 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Kojic. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Kojic acid accelerates fungicide degradation in papaya fruit by inducing the expression of tau class glutathione S-transferases
    Wang SY, Herrera-Balandrano DD, Cao JJ, et al. · Journal of hazardous materials · 2025 · 被引 3cited 3
  2. Comparative Stability of Two Anti-hyperpigmentation Agents: Kojic Acid as a Natural Metabolite and Its Di-Palmitate Ester, Under Oxidative Stress; Application to Pharmaceutical Formulation Design
    Tazesh S, Tamizi E, Siahi Shadbad M, et al. · Advanced pharmaceutical bulletin · 2022 · 被引 4cited 4

合成与制备工艺专利Synthesis & process patents

  1. Kojic acid plant growth regulator and preparation process thereof
    WEIRONG SHEN, LIPING HAN, JIAN SHEN, YING JIANG, et al. · 公开号 CN101444229CN101444229 · 2009
  2. Edible fungus fresh-keeping agent containing kojic acid and preparation technique thereof
    WEIRONG SHEN, LIPING HAN, JIAN SHEN, YING JIANG, et al. · 公开号 CN101455233CN101455233 · 2009
  3. Simple synthesis of kojic acid diester
    CHU BAI, HUANG LIANRONG · 公开号 CN1680352CN1680352 · 2005
  4. KOJIC ACID DERIVATIVE AND PREPARATION METHOD THEREOF
    JANG I SEOP, KIM BAE HWAN, KIM DEOK HUI, KIM SU NAM, et al. · 公开号 KR20040000638KR20040000638 · 2004
  5. KOJIC ACID DERIVATIVE AND PREPARATION METHOD THEREOF
    KIM DUCK HEE, RHO HO SIK, YOO JAE WON, BAEK HEUNG SOO, et al. · 公开号 WO02053562WO02053562 · 2002

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

曲酸 杂质谱研究要点Kojic — impurity profiling notes

下面这些是拿到 曲酸 的 32 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 32 impurity entries for Kojic, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances